Literature DB >> 17456546

Shock wave therapy for chronic plantar fasciopathy.

Jan D Rompe1, John Furia, Lowell Weil, Nicola Maffulli.   

Abstract

INTRODUCTION: Relevant data of randomized-controlled studies on shock wave treatment for chronic plantar fasciopathy are statistically and clinically heterogeneous.
METHODS: Randomized trials were identified form a current search of the Cochrane Bone, Joint and Muscle Trauma Group specialized register of trials, the Cochrane Central Register of Controlled Trials, MEDLINE and reference lists of articles and dissertations. We identified and retrieved a total of 17 articles. Methodological quality criterial included appropriate randomization, allocation concealment, blinding, number lost of follow-up and intention to treat analysis. Significant heterogeneity between studies precluded pooled analyses. Instead, individual trial results were described in the text.
RESULTS: We identified conflicting results in the 17 studies, involving more than 2100 participants. There was considerable heterogeneity in terms of methodological quality, treatment regimen, patient selection and follow-up period.
CONCLUSIONS: With current studies heterogenous in terms of the duration of the disorder; type, frequency and total dose of shock wave therapy (SWT); period of time between SWT; type of management and control group; timing of follow-up and outcomes assessed, a pooled meta-analysis of SWT for chronic plantar fasciopathy was considered inappropriate. Neverhteless, there was a preponderance of well-designed studies showing favourable results. It appears that one should only consider SWT for plantar fasciopathy after more common, accepted and proven non-invasive treatments have failed.

Entities:  

Mesh:

Year:  2007        PMID: 17456546     DOI: 10.1093/bmb/ldm005

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  34 in total

1.  A single application of low-energy radial extracorporeal shock wave therapy is effective for the management of chronic patellar tendinopathy.

Authors:  John P Furia; Jan D Rompe; Angelo Cacchio; Angelo Del Buono; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-05-25       Impact factor: 4.342

2.  Low-level laser therapy in the management of plantar fasciitis: a randomized controlled trial.

Authors:  Eda Cinar; Shikha Saxena; Fatma Uygur
Journal:  Lasers Med Sci       Date:  2017-12-23       Impact factor: 3.161

3.  Effectiveness of polydeoxyribonucleotide injection versus normal saline injection for treatment of chronic plantar fasciitis: a prospective randomised clinical trial.

Authors:  Jae Kwang Kim; Jae Yoon Chung
Journal:  Int Orthop       Date:  2015-04-29       Impact factor: 3.075

4.  Resistant plantar fasciopathy: shock wave versus endoscopic plantar fascial release.

Authors:  Yasser A Radwan; Ali M Reda Mansour; Walid S Badawy
Journal:  Int Orthop       Date:  2012-07-11       Impact factor: 3.075

5.  Dose-related effect of extracorporeal shock wave therapy for plantar fasciitis.

Authors:  Su-Jin Lee; Jung-Ho Kang; Ja-Young Kim; Jin-Hong Kim; Seo-Ra Yoon; Kwang-Ik Jung
Journal:  Ann Rehabil Med       Date:  2013-06-30

6.  The Dose-Related Effects of Extracorporeal Shock Wave Therapy for Knee Osteoarthritis.

Authors:  Jin-Hong Kim; Ja-Young Kim; Cheol-Min Choi; June-Kyung Lee; Hoi-Sung Kee; Kwang-Ik Jung; Seo-Ra Yoon
Journal:  Ann Rehabil Med       Date:  2015-08-25

Review 7.  Extracorporeal shock wave therapy is effective in treating chronic plantar fasciitis: a meta-analysis of RCTs.

Authors:  Adeel Aqil; Muhammad R S Siddiqui; Matthew Solan; David J Redfern; Vivek Gulati; Justin P Cobb
Journal:  Clin Orthop Relat Res       Date:  2013-06-28       Impact factor: 4.176

8.  Gold-Induced Cytokine (GOLDIC®) Injection Therapy in Patient with Plantar Fasciosis: A Case Report.

Authors:  Sergio Nicolas Sardon Melo; William D Murrell; Agnes Ezekwesili; Nagib A Yurdi; Nicola Maffulli
Journal:  Indian J Orthop       Date:  2020-03-26       Impact factor: 1.251

9.  Extracorporeal shock waves enhance normal fibroblast proliferation in vitro and activate mRNA expression for TGF-beta1 and for collagen types I and III.

Authors:  Laura Berta; Annamaria Fazzari; Anna Maria Ficco; Patrizia Maurici Enrica; Maria Graziella Catalano; Roberto Frairia
Journal:  Acta Orthop       Date:  2009-10       Impact factor: 3.717

10.  Pain relief by extracorporeal shockwave therapy: an update on the current understanding.

Authors:  Christoph Schmitz; Rocco DePace
Journal:  Urol Res       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.